141 related articles for article (PubMed ID: 36736346)
21. Crohn's disease induced by ocrelizumab in a patient with multiple sclerosis.
Carballo-Folgoso L; Celada-Sendino M; Castaño-García A; Oliva Nacarino P; Morales Del Burgo P; Pérez-Martínez I; de Francisco R; Riestra S
Rev Esp Enferm Dig; 2022 Dec; 114(12):766-767. PubMed ID: 36177822
[TBL] [Abstract][Full Text] [Related]
22. [Cytomegalovirus-induced colitis in an immunocompetent old patient].
Fleischer B; Morgenthaler J; Tippel G; Kuhfus A; Gieseler U; Stolte M
Med Klin (Munich); 2006 Oct; 101(10):835-8. PubMed ID: 17039327
[TBL] [Abstract][Full Text] [Related]
23. Ocrelizumab: A Review in Multiple Sclerosis.
Syed YY
CNS Drugs; 2018 Sep; 32(9):883-890. PubMed ID: 30171504
[TBL] [Abstract][Full Text] [Related]
24. Ocrelizumab for the treatment of multiple sclerosis.
Bigaut K; De Seze J; Collongues N
Expert Rev Neurother; 2019 Feb; 19(2):97-108. PubMed ID: 30570368
[TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus colitis during mycophenolate mofetil therapy for Wegener's granulomatosis.
Woywodt A; Choi M; Schneider W; Kettritz R; Göbel U
Am J Nephrol; 2000; 20(6):468-72. PubMed ID: 11146314
[TBL] [Abstract][Full Text] [Related]
26. Ocrelizumab treatment in multiple sclerosis: A Danish population-based cohort study.
Pontieri L; Blinkenberg M; Bramow S; Papp V; Rasmussen PV; Kant M; Schäfer J; Mathiesen HK; Jensen MB; Sirakov G; Berg JM; Kopp TI; Joensen H; Sellebjerg F; Magyari M
Eur J Neurol; 2022 Feb; 29(2):496-504. PubMed ID: 34644452
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus infection associated with inflammatory bowel disease.
Siegmund B
Lancet Gastroenterol Hepatol; 2017 May; 2(5):369-376. PubMed ID: 28397701
[TBL] [Abstract][Full Text] [Related]
28. Graves' disease with spontaneous resolution following ocrelizumab in primary progressive multiple sclerosis.
Duarte DB; Silva AMD; Freitas C; Cardoso H
Endocr Regul; 2021 Sep; 55(3):169-173. PubMed ID: 34523298
[No Abstract] [Full Text] [Related]
29. Case report: severe CMV colitis in a patient with follicular lymphoma after chemotherapy.
Polprasert C; Wongjitrat C; Wisedopas N
J Med Assoc Thai; 2011 Apr; 94(4):498-500. PubMed ID: 21591537
[TBL] [Abstract][Full Text] [Related]
30. Ocrelizumab-induced inflammatory bowel disease-like illness characterized by esophagitis and colitis.
Barnes A; Hofmann D; Hall LA; Klebe S; Mountifield R
Ann Gastroenterol; 2021; 34(3):447-448. PubMed ID: 33948072
[TBL] [Abstract][Full Text] [Related]
31. Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosis.
Malloy R; Fernandes R; Begun J; An YK
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36517079
[TBL] [Abstract][Full Text] [Related]
32. CMV colitis mimicking recurrent inflammatory bowel disease: report of three cases.
Rezania D; Ouban A; Marcet J; Kelley S; Coppola D
Am Surg; 2007 Jan; 73(1):58-61. PubMed ID: 17249458
[TBL] [Abstract][Full Text] [Related]
33. Ocrelizumab: First Global Approval.
Frampton JE
Drugs; 2017 Jun; 77(9):1035-1041. PubMed ID: 28523586
[TBL] [Abstract][Full Text] [Related]
34. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X; Hauser SL; Kappos L; Arnold DL; Bar-Or A; Comi G; de Seze J; Giovannoni G; Hartung HP; Hemmer B; Lublin F; Rammohan KW; Selmaj K; Traboulsee A; Sauter A; Masterman D; Fontoura P; Belachew S; Garren H; Mairon N; Chin P; Wolinsky JS;
N Engl J Med; 2017 Jan; 376(3):209-220. PubMed ID: 28002688
[TBL] [Abstract][Full Text] [Related]
35. Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy.
Patel A; Sul J; Gordon ML; Steinklein J; Sanguinetti S; Pramanik B; Purohit D; Haroutunian V; Williamson A; Koralnik I; Harel A
JAMA Neurol; 2021 Jun; 78(6):736-740. PubMed ID: 33724354
[TBL] [Abstract][Full Text] [Related]
36. Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis.
Buonomo AR; Saccà F; Zappulo E; De Zottis F; Lanzillo R; Gentile I; Carotenuto A; Borgia G; Russo CV
Mult Scler Relat Disord; 2019 Jan; 27():44-45. PubMed ID: 30316174
[TBL] [Abstract][Full Text] [Related]
37. CMV Infection in Pediatric IBD.
Yerushalmy-Feler A; Kern-Isaacs S; Cohen S
Curr Gastroenterol Rep; 2018 Mar; 20(4):13. PubMed ID: 29594760
[TBL] [Abstract][Full Text] [Related]
38. Routine Histology-Based Diagnosis of CMV Colitis Was Rare in Pediatric Patients.
Buck Q; Cho S; Mehta Walsh S; Schady D; Kellermayer R
J Pediatr Gastroenterol Nutr; 2022 Oct; 75(4):462-465. PubMed ID: 35706089
[TBL] [Abstract][Full Text] [Related]
39. [Additional possible mechanisms of the action of ocrelizumab in multiple sclerosis on example of a case-report].
Boyko OV; Khoroshylova II; Petrov SV; Lush NY; Guseva ME; Boyko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8. Vyp. 2):116-120. PubMed ID: 30160679
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis, Crypt Dropout, and Equivocal Immunohistochemical Staining May Indicate Cytomegalovirus Infection in Inflammatory Bowel Disease Patients.
Ono Y; Gonzalez RS
Am J Surg Pathol; 2023 Aug; 47(8):933-941. PubMed ID: 37326315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
